Saebo, Inc. Announces Delivery of its 50th In-Patient Kit
CHARLOTTE, N.C., Aug. 4 /PRNewswire/ — Saebo, Inc., a leading global provider of innovative stroke rehabilitation products for stroke survivors and other neurologically impaired patients, recently installed its 50th In-Patient Kit at the VA Medical Center in Atlanta, GA. Introduced in January 2008, Saebo’s In-Patient Kit has gained rapid acceptance, and allows stroke survivors to begin therapy while still in an acute-care setting.
“Our research and experience has shown that the sooner stroke survivors can begin task-oriented arm training post-stroke, the faster and more complete their potential recovery,” stated Henry Hoffman, Saebo’s President. “Hospitals like the In-Patient Kit because it gives them another tool to provide early intervention for upper extremity rehabilitation, which can lead to better outcomes and earlier discharges. Patients, of course, like working with the Saebo Program because it can help them regain function lost as a result of their stroke.”
The Saebo In-Patient Kit has been widely and rapidly embraced, both in the United States and abroad. In its first two years, the kit has been ordered for approximately half of the facilities of the largest in-patient rehab hospital chain in the US. Many other leading acute care rehabilitation hospitals in the US have also incorporated the In-Patient Kit into their programs. In the United Kingdom, the National Health Service has also integrated Saebo’s In-Patient Kit, installing them in over 10 hospitals in just the first six months of 2009. Other In-Patient Kits have been installed or ordered within leading hospitals in Canada, Germany and Austria.
About Saebo, Inc.
Saebo, Inc. is a leading global provider of innovative rehabilitation products for stroke survivors and neurologically impaired individuals. Headquartered in Charlotte, NC, the company was founded in 2001 by two brothers, Henry Hoffman and John Farrell, both practicing occupational therapists specializing in stroke rehabilitation. As the leading cause of long-term disability in the U.S., stroke affects over 700,000 Americans every year, leaving many with crippling side affects including the loss of hand function. Saebo’s pioneering treatment protocols are based on new research documenting the brain’s remarkable ability to “re-program” itself following injury. The company’s neurological orthotic devices, including the ground-breaking SaeboFlex and SaeboReach, allow patients with very little residual arm and hand function to immediately begin grasping and releasing objects in high repetition exercises, thereby forging new pathways in the brain. Named Most Valuable Product in 2008 by Therapy Times, the Saebo program is now offered as a treatment option at over 1,500 clinics and hospitals nationwide, including 22 of the “Top 25 Rehabilitation Hospitals” as ranked by U.S. News & World Report. The SaeboFlex is also eligible for reimbursement by Medicare and most commercial insurers. With a network of over 3,500 trained clinicians spanning four continents, Saebo is committed to helping stroke survivors around the globe achieve a new level of independence.
For more information, visit www.saebo.com.
Photos available upon request.
Available Topic Expert(s): For information on the listed expert(s), click appropriate link.
SOURCE Saebo, Inc.